Hematological Malignancies
📧 Sign up to get email alerts when something new happens for Hematological Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM [Phase 1, Phase 2]
Phase 1/2 clinical trial update for NiCord (umbilical cord blood-derived ex vivo expanded cells) in hematological malignancies, including AL…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Pasireotide in Prevention of GI Toxicity [Phase 2]
Phase 2 clinical trial evaluating pasireotide for prevention of GI toxicity in hematological malignancies has completed with posted results …
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies [Phase 2]
Phase 2 trial update exploring zinc as an enhancer of immune recovery after stem cell transplantation for hematological malignancies.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update on prevention of acute graft-versus-host disease in patients receiving allogeneic ApoGraft stem cell transplantation (…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating antibacterial prophylaxis versus no prophylaxis in hematological malignancy patients prior to allogene…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients [Phase 3]
Phase 3 trial assessing prevention of osteoporosis in bone marrow transplantation patients; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT [Phase 2]
Phase 2 trial evaluating tacrolimus and thymoglobulin as graft-versus-host disease prophylaxis in related donor hematopoietic cell transplan…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) [Phase 2]
A Phase 2 study investigating reduced-intensity pre-transplant conditioning prior to allogeneic hematopoietic stem cell transplantation for …
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT [NA]
This document notes an ongoing randomized controlled trial investigating whether an exercise program improves physical performance and quali…
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB) [Phase 1]
A Phase 1 trial evaluating allogeneic cord blood transplantation with ex vivo expansion was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area [Phase 4]
A Phase 4 trial reports a body surface area–based dosing regimen for posaconazole prophylaxis in children with hematological malignancies.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Reduced Intensity Haploidentical Transplant for Hematological Malignancies [Phase 1, Phase 2]
This clinical trial update presents results from Phase 1 and Phase 2 studies of reduced-intensity haploidentical transplantation for hematol…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies [Phase 1]
Phase 1 study of obatoclax mesylate (GX15-070MS) in hematological malignancies has completed. The update discusses safety and preliminary ef…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) [Phase 2]
Phase 2 trial update on thymoglobulin, sirolimus, and mycophenolate mofetil for preventing acute GVHD in hematologic malignancies; study ter…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients [Phase 3]
A Phase 3 trial evaluating whether concentrated citrate locking reduces central venous catheter-related complications in hematological patie…
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant
This is a completed prospective registry study tracking febrile events in patients with hematologic malignancies or after hematopoietic stem…
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: Intrabone Cord Blood Transplantation [Phase 4]
A Phase 4 clinical trial update for intrabone cord blood transplantation in hematological malignancies, with the trial status currently unkn…